It is a common assumption that exogenous antidiuretic hormone (Pitressing) is equal to the endogenous anti-diuretic hormone (ADH) in its ability to stimulate the production of a concentrated urine. However, clinical studies of urine formation after the administration of Pitressin'S or Pituitrin@ leave some doubt as to the ability of the exogenous hormone to produce a maximally concentrated urine. Sodeman and Engelhardt (1) found that if urinary specific gravity was low at the time of Pituitrin0 administration, the value attained was not so high as could be produced in the same subject by water deprivation. Similar observations were made by Little, Wallace, Whatley, and Anderson (2). Taylor, Peirce, and Page (3) gave Pituitrin@ at frequent intervals for 12 hours and found the urine to be often more dilute and of larger volume than after a 12-hour period of water deprivation. In every case the amounts of anti-diuretic hormone administered were much greater than are assumed to be normally produced.In the present study the ability of exogenous anti-diuretic hormone, administered as Pitressin@, to concentrate the urine has been reinvestigated in humans and in the dog. Because it is now recognized that the concentration of urine depends not only on the degree of hydropenia, but also on the prevailing rate of solute excretion (4-6), it seemed pertinent to investigate urinary concen- tration after Pitressin® administration during mild solute diuresis as well as under normal conditions of urine formation. To insure absence of circulating endogenous anti-diuretic hormone at the time PitressinD was tested, the subjects were hydrated and having a water diuresis at the start of hormone infusion. In evaluating the results, the urinary concentrations after Pitressins, expressed in milliosmols, have been compared with the urine osmolarity of hydropenic subjects, taking into account the fall in osmolarity normally occurring during solute diuresis.It was found that once water diuresis was inhibited by the administration of PitressinS, urine osmolarity slowly increased to approach, but rarely equal, values observed during hydropenia. Differences in plasma osmolarity in the hydratedPitressin(D and hydropenic groups accounted to some extent for the discrepancy. When urine osmolarity was expressed as a function of plasma osmolarity, either as the osmotic U/P ratio or the urine-plasma osmotic pressure difference, values after a sufficient period of Pitressin@ infusion were often comparable to those of hydropenic subjects providing solute diuresis was present. In the absence of solute diuresis, the results were not as consistent. Prolonged Pitressin® administration in several instances failed to elevate osmotic pressure differentials to values observed in hydropenic subjects.
METHODSFor the study 32 experiments were performed, 17 on eight female mongrel dogs and 15 on five male subjects. At least two experiments were usually performed on each subject, one to determine urinary concentration during hydropenia and a second to test the eff...